Echocardiography in Critically-ill Patients With COVID-19 Pneumonia
NCT ID: NCT04414410
Last Updated: 2021-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2020-05-12
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hemodynamic Characteristics of Patients With SARS-CoV-2
NCT04337983
Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19
NCT04567927
Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO
NCT04405973
Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19
NCT04379544
The Role of Ultrasound in COVID-19
NCT04377035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Ambroise Paré Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof Antoine Vieillard-Baron
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antoine Vieillard-Baron, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Ambroise Paré Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Ambroise Pare
Boulogne-Billancourt, Hauts De Seine, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Huang S, Vieillard-Baron A, Evrard B, Prat G, Chew MS, Balik M, Clau-Terre F, De Backer D, Mekontso Dessap A, Orde S, Morelli A, Sanfilippo F, Charron C, Vignon P; ECHO-COVID study group. Echocardiography phenotypes of right ventricular involvement in COVID-19 ARDS patients and ICU mortality: post-hoc (exploratory) analysis of repeated data from the ECHO-COVID study. Intensive Care Med. 2023 Aug;49(8):946-956. doi: 10.1007/s00134-023-07147-z. Epub 2023 Jul 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RedCap19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.